Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | BuyD (derivative) | $5T | SEC | ||
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | BuyD (derivative) | $5T | SEC | ||
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | BuyD (derivative) | $3.5T | SEC | ||
OMNI BIO PHARMACEUTICAL, INC.Listing unverified | BuyD (derivative) | $1.3T | First in 12mo | SEC |